| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CombiGene AB (publ) (ST: COMBI)
COMBI Technical Analysis
5
| As on 9th Jun 2023 COMBI STOCK Price closed @ 6.96 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 9.04 & Strong Sell for SHORT-TERM with Stoploss of 10.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
COMBISTOCK Price
| Open | 6.75 | Change | Price | % |
| High | 7.00 | 1 Day | 0.21 | 3.11 |
| Low | 6.62 | 1 Week | 0.36 | 5.45 |
| Close | 6.96 | 1 Month | 0.33 | 4.98 |
| Volume | 12024 | 1 Year | -4.84 | -41.02 |
| 52 Week High 11.80 | 52 Week Low 6.60 | ||||
ST Sweden Most Active Stocks
| QUIA | 0.02 | 0.00% |
| QLIFE | 0.04 | 0.00% |
| SBB-B | 5.38 | 3.07% |
| STRLNG | 0.12 | 33.33% |
| LUNE | 21.97 | 6.65% |
| SAS | 0.36 | 5.88% |
| URBIT | 0.02 | 0.00% |
| IDOGEN | 0.15 | -31.82% |
| STAR-B | 0.89 | -1.11% |
| TELIA | 24.60 | 0.41% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| COMBI Daily Charts |
COMBI Intraday Charts |
Whats New @ Bazaartrend |
COMBI Free Analysis |
|
|
COMBI Important Levels Intraday
| RESISTANCE | 7.69 |
| RESISTANCE | 7.46 |
| RESISTANCE | 7.31 |
| RESISTANCE | 7.17 |
| SUPPORT | 6.75 |
| SUPPORT | 6.61 |
| SUPPORT | 6.46 |
| SUPPORT | 6.23 |
COMBI Forecast May 2024
| 4th UP Forecast | 11.2 |
| 3rd UP Forecast | 9.84 |
| 2nd UP Forecast | 9 |
| 1st UP Forecast | 8.16 |
| 1st DOWN Forecast | 5.76 |
| 2nd DOWN Forecast | 4.92 |
| 3rd DOWN Forecast | 4.08 |
| 4th DOWN Forecast | 2.72 |
COMBI Weekly Forecast
| 4th UP Forecast | 9.66 |
| 3rd UP Forecast | 8.79 |
| 2nd UP Forecast | 8.26 |
| 1st UP Forecast | 7.72 |
| 1st DOWN Forecast | 6.20 |
| 2nd DOWN Forecast | 5.66 |
| 3rd DOWN Forecast | 5.13 |
| 4th DOWN Forecast | 4.26 |
COMBI Forecast2024
| 4th UP Forecast | 17.81 |
| 3rd UP Forecast | 14.33 |
| 2nd UP Forecast | 12.18 |
| 1st UP Forecast | 10.03 |
| 1st DOWN Forecast | 3.89 |
| 2nd DOWN Forecast | 1.74 |
| 3rd DOWN Forecast | -0.41 |
| 4th DOWN Forecast | -3.89 |
CombiGene AB (publ) ( ST Sweden Symbol : COMBI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
COMBI Business Profile
CombiGene AB (publ) engages in the development and commercialization of gene therapy for the treatment of neurological and psychiatric disorders. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy. CombiGene AB (publ) was founded in 1999 and is headquartered in Lund, Sweden. Address: ScheelevAegen 2, Lund, Sweden, 223 81
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service